The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Bayer AGEU/1/13/907/013-015

Main Information

Trade NameAdempas
Active SubstancesRiociguat
Dosage FormFilm-coated tablet
Licence HolderBayer AG
Licence NumberEU/1/13/907/013-015

Group Information

ATC CodeC02KX Other antihypertensives
C02KX05 Antihypertensives for pulmonary arterial hypertension


License statusAuthorised
Licence Issued27/03/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusNot marketed


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back